Meetings and Courses

Meetings and Courses

Announcements for this section should be submitted in the correct format at least 3 months before the required date of publication. This list is provided as a service to readers;inclusion does not imply endorsement by the Hepatobiliary& Pancreatic Diseases International.

Section editor

Shui-Ying Lei

Email: hbpdint@126.com

October, 2017

6th international conference on clinical and medical case reports (ICMCR)

October 16-18, 2017; San Francisco, United States

ICMCR 2017 cordially welcomes high quality late breaking abstract (case reports and clinical research) submissions in following specialties: internal medicine, surgery and all sub-specialties including cardiovascular diseases,gastrointestinal and hepatic diseases, respiratory disorders, infectious diseases, endocrine and metabolic disorders, hematology, musculoskeletal disorders, allergy-immunology, oncology, rare/orphan diseases, renal diseases,rheumatology, genetic disorders, geriatrics, and other. For more information, please contact: Email: casereportsamerica@conferenceseries.net; website: http://casereports.conferenceseries.com/.

United European Gastroenterology (UEG) week Barcelona 2017

October 28-November 1, 2017; Barcelona, Spain

November

EMBL conference: cancer genomics

November 5-8, 2017; Heidelberg, Germany

2017 national cancer research institute (NCRI) cancer conference

November 5-8, 2017; Liverpool, United Kingdom

Frontiers in cancer science 2017

November 6-8, 2017; Singapore, Singapore

7th annual conference on enhanced recovery aer surgery (UK)

November 10, 2017; Gateshead, United Kingdome 7th conference will feature seminars from centres of excellence, abstract presentations and breakout sessions for various specialties and roles. Co-chairs are Professor Alan Horgan (Freeman Hospital, Newcastle) and Mr Mike Reed (Northumbria NHS). For more information,please visit: http://www.erasuk.net/conference-2017.html.

Global experts meeting on gastroenterology

November 13-14, 2017; Melbourne, Australia

Oncology clinical experience

November 21-23, 2017; Leeds, United Kingdom

Oncology Clinical Experience offers rapid and progressive face-to-face training taught by clinician experts and the care team.is course thoroughly equips attendees with theoretical and practical knowledge to discuss Oncology and its treatment confidently and credibly. Participants are provided with an overview of the spectrum of malignant disease and there is unique opportunity for delegates to experience – first hand – the assessment and treatment options utilised within the overall management of patients with malignant disease. Open discussions and case presentations form a key part of the programme. Topics include: 1) Introduction to oncology and the epidemiology of cancer; 2) Overview of available therapies, current chemotherapy, immunotherapy and radiotherapy practice; 3) Common solid tumour types breast, lung, colorectal, gastrointestinal, melanoma, renal; 4) New therapeutic options in oncology including immunotherapies; 5) Department visits: radiotherapy and chemotherapy suites, outpatient clinics and radiology department. For more information, please visit:https://www.healthcare-ed.com/.

Oncology trials: focus on phase III

November 29-30, 2017; London, United Kingdom

Phase III Trials is a high calibre, two-day training programme presented in London, UK.is interactive and informative course provides a comprehensive overview of the planning and implementation of oncology clinical trials, focusing on Phase III.e course will demonstrate how oncology trials differ in design and conduct from those in other therapy areas. Delegates learn to design trials to minimise the deficiencies that lead to inappropriate interpretation whilst maximising the competitive advantage. Delegates will hear the perspective of currently practicing oncologists with extensive experience of industry clinical trials as well as professionals who will discuss oncology clinical trial statistics and oncology product market entry. Topics include: 1) Introduction to oncology clinical trial design and planning;2) Informed consent/patient information; 3)e impact of trials on clinical practice; 4) Statistical analysis and reporting; 5) Health economics assessment; 6) Quality of life assessment. For more information, please visit:https://www.healthcare-ed.com/.

December

Gastroenterology Hawaiian Islands cruise

December 2-9, 2017; Honolulu, United States

10.1016/S1499-3872(17)60068-7)